CI Platform
Sign in
HJ Science Co., Ltd. Class H6132HKG
Current ReportFundamental Reports

Asia / HONG KONG

Report Sections1

Available for this company

Reporting UnitMillions

HKG

To continue to view the full report

Buy this company's report, or subscribe to a plan.

Buy ReportSubscribe PlansAlready a member? Sign in

Company Overview

HJ Science Co., Ltd. operates as a clinical-stage biotechnology that researches and develops innovative small-molecule drugs for autoimmune, metabolic, and oncology diseases. The company was founded in 2017 by Jian Xin Ji and is headquartered in Chengdu, China.

HJ Science Co., Ltd. operates as a clinical-stage biotechnology that researches and develops innovative small-molecule drugs for autoimmune, metabolic, and oncology diseases. The company was founded in 2017 by Jian Xin Ji and is headquartered in Chengdu, China.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryBiological Products Exc. Diagnostic
CountryHONG KONG
Employees115
Reporting UnitMillions
Primary ExchangeHKG
Instrument TypeEquity
Wright IDC344S8H05

Key Metrics

Current price$30.16
Market cap$2.22 B
P/E ration/a
Common shares73.6 M
Share typeH Gu
Quality ratingDDD0
Dividend yieldn/a

Recent stock performance

1 Week+12.5%
4 Week-15.7%
13 Week-25.5%

Officers

n/a

Address

HONG KONG

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.